Efficacy, safety and cost-effectiveness of 40 mg versus 80 mg atorvastatin in a Sri Lankan cohort with acute coronary syndrome: a protocol for a single-centre randomised controlled clinical trial
Authors
K. Fernando (ORCID: https://orcid.org/0000-0002-2429-8783)
Efficacy, safety and cost-effectiveness of 40 mg versus 80 mg atorvastatin in a Sri Lankan cohort with acute coronary syndrome: a protocol for a single-centre randomised controlled clinical trial
K. Fernando, Chamila Mettananda, B. K. T. P. Dayanath, Chiranthi Welhenge et al.
Journal
Trials
Topics
Lipoproteins and Cardiovascular Health
article
Efficacy, safety and cost-effectiveness of 40 mg versus 80 mg atorvastatin in a Sri Lankan cohort with acute coronary syndrome: a protocol for a single-centre randomised controlled clinical trial
K. Fernando, Chamila Mettananda, B. K. T. P. Dayanath, Chiranthi Welhenge, Nilshan Fernando, Shamila De Silva, Shashima Liyanage
article en
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 26(1)
Institutions
University of Kelaniya (LK), Colombo North Teaching Hospital (LK)